Health Catalyst (HCAT)
NASDAQ:HCAT
Want to see HCAT full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.03Last Year’s EPS
0.04Same Quarter Last Year
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call balanced clear operational and financial progress with meaningful near-term headwinds. Positives include a revenue beat, improved adjusted gross margin, a sizable adjusted EBITDA beat, strong cash generation, a detailed restructuring program (Project NEXUS) targeting ~$30M of annualized savings, early product and AI traction, and reinstated full-year guidance. Negatives center on migration-driven churn (~$30M at-risk ARR with an expected ~$20M 2026 impact), transitional duplicate hosting and data-loading costs weighing on margins, expected professional services margin decline, and near-term restructuring charges and execution risk. Overall, management laid out a coherent plan to address issues and improve long-term durability but acknowledged short-term revenue and margin pressure tied to migration and transformation.Company Guidance
Revenue Beat and Top-Line Composition
Q1 2026 total revenue $70.8M, exceeding the high end of guidance ($68M–$70M). Technology revenue $49.5M (vs. professional services $21.3M), reflecting the strategic mix shift toward higher-margin technology offerings.
Adjusted EBITDA and Margin Improvement
Adjusted EBITDA of $9.1M beat guidance ($7M–$8M) and increased from $6.3M in Q1 2025 (~+44%). Adjusted gross margin improved to 51.5% from 49.2% year-over-year (+2.3 percentage points).
Operating Expense Discipline and Cost Reductions
Adjusted operating expenses decreased to $27.3M (39% of revenue) from $32.8M (41% of revenue) in Q1 2025 — a reduction of $5.5M (~16.8%). Management expects quarterly adjusted operating expenses to decrease by $3M–$4M versus Q1 as Project NEXUS actions ramp.
Strong Cash Position and Cash Generation
Cash, cash equivalents and short-term investments of ~$108.8M at quarter end, a $13.1M increase versus December 31, 2025, supporting liquidity while transformation actions unfold.
Project NEXUS Cost Savings and Structural Plan
Announced Project NEXUS targeting ~ $30M of annualized run-rate savings (includes ~$22M direct savings from a 9% headcount reduction and non-headcount cuts, plus ~$8M indirect savings). Majority of restructuring charges (~$4M) expected in Q2; program substantially complete by year-end.
Product & AI Momentum and Development Productivity Gains
Focused AI strategy built on 18 years of proprietary improvement data; customer feedback on Ignite Intelligence (early cost-management capability) reportedly positive. Engineering pilot using efficient pods and AI agents increased story points delivered by as much as 100% per developer in initial tests.
Reinstated Guidance and Bookings Metric
Reintroduced full-year 2026 guidance: revenue $260M–$265M and adjusted EBITDA $30M–$33M. Introduced 'total bookings' as an operating metric and expects $22M–$26M in new bookings for 2026; management notes bookings typically convert to revenue in ~3–6 months.
HCAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HCAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 11, 2026 | $1.38 | $1.48 | +7.25% |
Mar 12, 2026 | $1.79 | $1.32 | -26.26% |
Nov 10, 2025 | $2.85 | $2.69 | -5.61% |
Aug 07, 2025 | $3.69 | $2.83 | -23.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Health Catalyst (HCAT) report earnings?
Health Catalyst (HCAT) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
What is Health Catalyst (HCAT) earnings time?
Health Catalyst (HCAT) earnings time is at Aug 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HCAT EPS forecast?
HCAT EPS forecast for the fiscal quarter 2026 (Q2) is 0.03.
